Search

everythinglearnresearchcommunity

for

Search:↓

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document is a detailed medical reference on skin and genetic disorders.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

More research with diverse participants is needed to determine the effectiveness of photobiomodulation devices for hair loss treatment.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Gray hair regained color after thyroid hormone treatment.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Mogamulizumab can cause hair loss and skin rashes.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Diagnosing mycosis fungoides, a rare skin cancer, is difficult in elderly adults and requires careful examination to avoid mistaking it for less serious skin conditions.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Low-dose oral minoxidil increases hair thickness and length in children with a hair disorder called Loose Anagen Hair Syndrome.

Vitamin D is crucial for skin health and managing skin diseases.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.